SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 258,294.28 |
Enterprise Value ($M) | 289,594.28 |
Book Value ($M) | 46,905.00 |
Book Value / Share | 18.48 |
Price / Book | 5.51 |
NCAV ($M) | -35,750.00 |
NCAV / Share | -14.09 |
Price / NCAV | -7.23 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.04 |
Return on Assets (ROA) | 0.03 |
Return on Equity (ROE) | 0.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.03 |
Current Ratio | 1.28 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 29,977.00 |
Assets | 104,469.00 |
Liabilities | 65,727.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 8.96 | 7.58 | |
13G/A | BlackRock Inc. | 8.50 | 8.47 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S | ||
Form 10-Q | ||
Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
587,588 | 4,589,403 | 12.80 | |
673,476 | 5,590,039 | 12.05 | |
601,495 | 7,232,722 | 8.32 | |
318,618 | 4,758,881 | 6.70 | |
(click for more detail) |
Similar Companies | |
---|---|
JNJ – Johnson & Johnson | LCI – Lannett Co., Inc. |
LLY – Lilly(Eli) & Co | MYOV – Myovant Sciences Ltd |
NUVB – Nuvation Bio Inc – Class A |